Literature DB >> 3516883

Monoclonal antibodies reactive with K1-encapsulated Escherichia coli lipopolysaccharide are opsonic and protect mice against lethal challenge.

B M Kaufman, A S Cross, S L Futrovsky, H F Sidberry, J C Sadoff.   

Abstract

Seven murine monoclonal antibodies (MAbs) directed against O-side-chain determinants of the K1-encapsulated Bortolussi strain of Escherichia coli (O18:K1:H7) were evaluated for their in vitro and in vivo activities. All the MAbs reacted well in Western blots against E. coli O18 lipopolysaccharide antigens. Two MAbs of the immunoglobulin G (IgG) class promoted in vitro opsonophagocytosis and protected mice lethally challenged with bacteria. Two IgM MAbs showed partial protection, although they had no in vitro opsonic activity, and the remaining three IgM MAbs showed no apparent functional activities. Monoclonal IgG antibodies against bacterial lipopolysaccharide can be opsonic and protective in spite of the presence of the K1 capsule on the bacterium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3516883      PMCID: PMC261046          DOI: 10.1128/iai.52.2.617-619.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

Authors:  J W LITTLEFIELD
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

2.  Immunoenzymatic analysis by monoclonal antibodies of bacterial lipopolysaccharides after transfer to nitrocellulose.

Authors:  H Sidberry; B Kaufman; D C Wright; J Sadoff
Journal:  J Immunol Methods       Date:  1985-02-11       Impact factor: 2.303

3.  An immunoprotective monoclonal antibody to lipopolysaccharide.

Authors:  T N Kirkland; E J Ziegler
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

4.  The importance of the K1 capsule in invasive infections caused by Escherichia coli.

Authors:  A S Cross; P Gemski; J C Sadoff; F Orskov; I Orskov
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

5.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

6.  Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1.

Authors:  G Pluschke; M Achtman
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

7.  Parameters affecting ascites tumour formation in mice and monoclonal antibody production.

Authors:  B R Brodeur; P Tsang; Y Larose
Journal:  J Immunol Methods       Date:  1984-07-06       Impact factor: 2.303

8.  Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.

Authors:  R Bortolussi; P Ferrieri; B Björkstén; P G Quie
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli.

Authors:  A S Cross; W Zollinger; R Mandrell; P Gemski; J Sadoff
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

  9 in total
  8 in total

1.  Impaired colonization by and full invasiveness of Escherichia coli K1 bearing a site-directed mutation in the type 1 pilin gene.

Authors:  C A Bloch; P E Orndorff
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

2.  Pathogenicity island evaluation in Escherichia coli K1 by crossing with laboratory strain K-12.

Authors:  C A Bloch; C K Rode
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

3.  Influence of some bacterial and host factors on colonization and invasiveness of Escherichia coli K1 in neonatal rats.

Authors:  M Wullenweber; L Beutin; S Zimmermann; C Jonas
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

4.  Role of antibodies in the opsonization of Yersinia spp.

Authors:  R Tertti; E Eerola; K Granfors; R Lahesmaa-Rantala; K Pekkola-Heino; A Toivanen
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

5.  Administration in vivo of recombinant interleukin 2 protects mice against septic death.

Authors:  C Weyand; J Goronzy; C G Fathman; P O'Hanley
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

6.  Use of hybridoma immunoglobulin switch variants in the analysis of the protective properties of anti-lipopolysaccharide antibodies in Escherichia coli K1 infection.

Authors:  S Pelkonen; G Pluschke
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

7.  Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa.

Authors:  J S Lam; L A MacDonald; M Y Lam; L G Duchesne; G G Southam
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

8.  MUC1 ectodomain is a flagellin-targeting decoy receptor and biomarker operative during Pseudomonas aeruginosa lung infection.

Authors:  Avelino C Verceles; Pavan Bhat; Zain Nagaria; Destiny Martin; Harsh Patel; Afua Ntem-Mensah; Sang W Hyun; Andrea Hahn; Jean Jeudy; Alan S Cross; Erik P Lillehoj; Simeon E Goldblum
Journal:  Sci Rep       Date:  2021-11-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.